Coagulation/Hemostasis Analyzer Market by Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) - Forecast to 2021
The coagulation analyzers market is projected to reach USD 4.84 billion by 2021 from USD 2.98 billion in 2016, at a CAGR of 10.2% from 2016 to 2021. The global coagulation analyzers market is segmented based on product, test, technology, end-users and regions. The clinical laboratory analyzers segment is expected to register the highest growth rate in the consumables market, by product, during the forecast period. The high growth in this segment is attributed to the increasing rental agreements and increasing prevalence of autoimmune diseases worldwide. Moreover, high cost of coagulation analyzers and slow adoption of advanced hemostasis instruments in emerging economies is restraining the growth of this market.
Based on end-users, the coagulation analyzers market are classified into clinical laboratories, PoC testing and others. The clinical laboratories segment is expected to account for the largest share of the global coagulation analyzers market in 2016. Increasing prevalence of CVD’s and the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories will drive the growth of this market.
Geographically, the coagulation analyzers market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by increasing aging population and increasing prevalence of CVD’s.
The major factors contributing to the growth of the coagulation analyzers market include increasing high incidences of CVD’s, increasing blood related disorders, and rising geriatric population. On the other hand, slow adoption of advanced hemostasis instruments in emerging economies and high cost of fully automated hemostasis analyzers are the major factors restraining the growth of this market. The high growth potential in the Asian region provides growth opportunities to players in the coagulation analyzers market.
The major players in this market include are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), and International Technidyne Corporation (U.S.).
Research Coverage
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach and levels of output in order to remain successful in the coagulation analyzers market.
Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
Based on end-users, the coagulation analyzers market are classified into clinical laboratories, PoC testing and others. The clinical laboratories segment is expected to account for the largest share of the global coagulation analyzers market in 2016. Increasing prevalence of CVD’s and the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories will drive the growth of this market.
Geographically, the coagulation analyzers market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by increasing aging population and increasing prevalence of CVD’s.
The major factors contributing to the growth of the coagulation analyzers market include increasing high incidences of CVD’s, increasing blood related disorders, and rising geriatric population. On the other hand, slow adoption of advanced hemostasis instruments in emerging economies and high cost of fully automated hemostasis analyzers are the major factors restraining the growth of this market. The high growth potential in the Asian region provides growth opportunities to players in the coagulation analyzers market.
The major players in this market include are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), and International Technidyne Corporation (U.S.).
Research Coverage
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach and levels of output in order to remain successful in the coagulation analyzers market.
Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the coagulation analyzers market. The report analyses the coagulation analyzers market by product, test type, technology, and end users.
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the coagulation analyzers market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the coagulation analyzers market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various coagulation analyzers across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the coagulation analyzers market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKETS COVERED
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 SECONDARY DATA
2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2 PRIMARY DATA
2.2.1 KEY DATA FROM PRIMARY SOURCES
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CONCLUSION
4 PREMIUM INSIGHTS
4.1 COAGULATION ANALYZERS MARKET OVERVIEW
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing Prevalence of Cardiovascular Diseases and Blood Disorders
5.2.1.2 Rising Aging Population
5.2.1.3 Development of High-sensitivity PoC Coagulation Testing
5.2.1.4 Increasing Laboratory Automation
5.2.2 RESTRAINT
5.2.2.1 High Cost of Fully Automated Coagulation Analyzers
5.2.3 OPPORTUNITY
5.2.3.1 Emerging Markets
5.2.4 CHALLENGE
5.2.4.1 Slow Adoption of Advanced Hemostasis Instruments in Emerging Economies
6 COAGULATION ANALYZERS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CLINICAL LABORATORY ANALYZERS
6.2.1 CONSUMABLES
6.2.1.1 Reagents
6.2.1.2 Standards, Controls, and Calibrations
6.2.2 SYSTEMS
6.2.2.1 Automated Systems
6.2.2.2 Semiautomated Systems
6.2.2.3 Manual Systems
6.3 POINT-OF-CARE TESTING ANALYZERS
7 COAGULATION ANALYZERS MARKET, BY TEST
7.1 INTRODUCTION
7.2 PROTHROMBIN TIME TESTING
7.3 FIBRINOGEN TESTING
7.4 ACTIVATED CLOTTING TIME TESTING
7.5 ACTIVATED PARTIAL THROMBOPLASTIN TIME TESTING
7.6 D-DIMER TESTING
7.7 PLATELET FUNCTION TESTS
7.8 ANTI-FACTOR XA TESTS
7.9 HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT
7.10 OTHER COAGULATION TESTS
8 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
8.2 OPTICAL TECHNOLOGY
8.3 MECHANICAL TECHNOLOGY
8.4 ELECTROCHEMICAL TECHNOLOGY
8.5 OTHER TECHNOLOGIES
9 COAGULATION ANALYZERS MARKET, BY PATIENT CARE SETTING
9.1 INTRODUCTION
9.2 CLINICAL LABORATORIES
9.3 POINT-OF-CARE TESTING
9.4 OTHER END USERS
10 COAGULATION ANALYZERS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 U.K.
10.3.3 FRANCE
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 REST OF EUROPE (ROE)
10.4 ASIA
10.4.1 CHINA
10.4.2 JAPAN
10.4.3 INDIA
10.4.4 REST OF ASIA (ROA)
10.5 REST OF THE WORLD (ROW)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 STRATEGIC OVERVIEW
11.3 MARKET SHARE ANALYSIS
11.4 COMPETITIVE SITUATION AND TRENDS
11.4.1 PRODUCT LAUNCHES
11.4.2 EXPANSIONS
11.4.3 AGREEMENTS
11.4.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 INTRODUCTION
12.2 ALERE INC.
12.3 NIHON KOHDEN CORPORATION
12.4 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.)
12.5 SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG)
12.6 SYSMEX CORPORATION
12.7 THERMO FISHER SCIENTIFIC INC.
12.8 DIAGNOSTICA STAGO SAS
12.9 HELENA LABORATORIES
12.10 INSTRUMENTATION LABORATORY (A DIVISION OF THE WERFEN GROUP)
12.11 INTERNATIONAL TECHNIDYNE CORPORATION (ITC)
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKETS COVERED
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 SECONDARY DATA
2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2 PRIMARY DATA
2.2.1 KEY DATA FROM PRIMARY SOURCES
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CONCLUSION
4 PREMIUM INSIGHTS
4.1 COAGULATION ANALYZERS MARKET OVERVIEW
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing Prevalence of Cardiovascular Diseases and Blood Disorders
5.2.1.2 Rising Aging Population
5.2.1.3 Development of High-sensitivity PoC Coagulation Testing
5.2.1.4 Increasing Laboratory Automation
5.2.2 RESTRAINT
5.2.2.1 High Cost of Fully Automated Coagulation Analyzers
5.2.3 OPPORTUNITY
5.2.3.1 Emerging Markets
5.2.4 CHALLENGE
5.2.4.1 Slow Adoption of Advanced Hemostasis Instruments in Emerging Economies
6 COAGULATION ANALYZERS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CLINICAL LABORATORY ANALYZERS
6.2.1 CONSUMABLES
6.2.1.1 Reagents
6.2.1.2 Standards, Controls, and Calibrations
6.2.2 SYSTEMS
6.2.2.1 Automated Systems
6.2.2.2 Semiautomated Systems
6.2.2.3 Manual Systems
6.3 POINT-OF-CARE TESTING ANALYZERS
7 COAGULATION ANALYZERS MARKET, BY TEST
7.1 INTRODUCTION
7.2 PROTHROMBIN TIME TESTING
7.3 FIBRINOGEN TESTING
7.4 ACTIVATED CLOTTING TIME TESTING
7.5 ACTIVATED PARTIAL THROMBOPLASTIN TIME TESTING
7.6 D-DIMER TESTING
7.7 PLATELET FUNCTION TESTS
7.8 ANTI-FACTOR XA TESTS
7.9 HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT
7.10 OTHER COAGULATION TESTS
8 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
8.2 OPTICAL TECHNOLOGY
8.3 MECHANICAL TECHNOLOGY
8.4 ELECTROCHEMICAL TECHNOLOGY
8.5 OTHER TECHNOLOGIES
9 COAGULATION ANALYZERS MARKET, BY PATIENT CARE SETTING
9.1 INTRODUCTION
9.2 CLINICAL LABORATORIES
9.3 POINT-OF-CARE TESTING
9.4 OTHER END USERS
10 COAGULATION ANALYZERS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 U.K.
10.3.3 FRANCE
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 REST OF EUROPE (ROE)
10.4 ASIA
10.4.1 CHINA
10.4.2 JAPAN
10.4.3 INDIA
10.4.4 REST OF ASIA (ROA)
10.5 REST OF THE WORLD (ROW)
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 STRATEGIC OVERVIEW
11.3 MARKET SHARE ANALYSIS
11.4 COMPETITIVE SITUATION AND TRENDS
11.4.1 PRODUCT LAUNCHES
11.4.2 EXPANSIONS
11.4.3 AGREEMENTS
11.4.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 INTRODUCTION
12.2 ALERE INC.
12.3 NIHON KOHDEN CORPORATION
12.4 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.)
12.5 SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG)
12.6 SYSMEX CORPORATION
12.7 THERMO FISHER SCIENTIFIC INC.
12.8 DIAGNOSTICA STAGO SAS
12.9 HELENA LABORATORIES
12.10 INSTRUMENTATION LABORATORY (A DIVISION OF THE WERFEN GROUP)
12.11 INTERNATIONAL TECHNIDYNE CORPORATION (ITC)
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 EXAMPLES OF POC COAGULATION ANALYZERS BY LEADING PLAYERS
Table 2 COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 3 CLINICAL LABORATORY ANALYZERS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 4 CLINICAL LABORATORY ANALYZERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 5 CLINICAL LABORATORY ANALYZERS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014–2021 (USD MILLION)
Table 6 CLINICAL LABORATORY ANALYZERS MARKET SIZE FOR CONSUMABLES, BY REGION, 2014–2021 (USD MILLION)
Table 7 CONSUMABLES MARKET SIZE FOR REAGENTS, BY REGION, 2014–2021 (USD MILLION)
Table 8 CONSUMABLES MARKET SIZE FOR STANDARDS, CONTROLS, AND CALIBRATIONS, BY REGION, 2014–2021 (USD MILLION)
Table 9 CLINICAL LABORATORY ANALYZERS MARKET SIZE FOR SYSTEMS, BY TYPE, 2014–2021 (USD MILLION)
Table 10 CLINICAL LABORATORY ANALYZERS MARKET SIZE FOR SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 11 AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 12 SEMIAUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 13 MANUAL SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 14 POC TESTING ANALYZERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 15 COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 16 PROTHROMBIN TIME TESTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 17 FIBRINOGEN TESTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 18 ACT TESTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 19 APTT TESTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 20 D-DIMER TESTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 21 PLATELET FUNCTION TESTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 22 ANTI-FACTOR XA TESTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 23 HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 24 OTHER COAGULATION TESTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 25 COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 26 OPTICAL TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 27 MECHANICAL TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 28 ELECTROCHEMICAL TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 29 OTHER TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 30 COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 31 CLINICAL LABORATORIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 32 POINT-OF-CARE TESTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 33 OTHER END USERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 34 COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 35 LIST OF RELATED CONFERENCES HELD IN NORTH AMERICA
Table 36 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 37 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 38 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 39 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 40 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 41 U.S.: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 42 U.S.: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 43 U.S.: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 44 CANADA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 45 CANADA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 46 CANADA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 47 EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 48 EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 49 EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 50 EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 51 EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 52 GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 53 GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 54 GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 55 U.K.: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 56 U.K.: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 57 U.K.: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 58 FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 59 FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 60 FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 61 ITALY: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 62 ITALY: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 63 ITALY: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 64 SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 65 SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 66 SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 67 ROE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 68 ROE: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 69 ROE: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 70 ASIA: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 71 ASIA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 72 ASIA: COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 73 ASIA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 74 ASIA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 75 CHINA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 76 CHINA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 77 CHINA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 78 JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 79 JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 80 JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 81 INDIA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 82 INDIA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 83 INDIA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 84 ROA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 85 ROA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 86 ROA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 87 ROW: COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 88 ROW: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 89 ROW: COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 90 ROW: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 91 ROW: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 92 GROWTH STRATEGY MATRIX, 2014–2016
Table 93 PRODUCT LAUNCHES, 2014–2016
Table 94 EXPANSIONS, 2014–2016
Table 95 AGREEMENTS, 2014–2016
Table 96 OTHER DEVELOPMENTS, 2014–2016
Table 1 EXAMPLES OF POC COAGULATION ANALYZERS BY LEADING PLAYERS
Table 2 COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 3 CLINICAL LABORATORY ANALYZERS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 4 CLINICAL LABORATORY ANALYZERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 5 CLINICAL LABORATORY ANALYZERS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014–2021 (USD MILLION)
Table 6 CLINICAL LABORATORY ANALYZERS MARKET SIZE FOR CONSUMABLES, BY REGION, 2014–2021 (USD MILLION)
Table 7 CONSUMABLES MARKET SIZE FOR REAGENTS, BY REGION, 2014–2021 (USD MILLION)
Table 8 CONSUMABLES MARKET SIZE FOR STANDARDS, CONTROLS, AND CALIBRATIONS, BY REGION, 2014–2021 (USD MILLION)
Table 9 CLINICAL LABORATORY ANALYZERS MARKET SIZE FOR SYSTEMS, BY TYPE, 2014–2021 (USD MILLION)
Table 10 CLINICAL LABORATORY ANALYZERS MARKET SIZE FOR SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 11 AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 12 SEMIAUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 13 MANUAL SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 14 POC TESTING ANALYZERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 15 COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 16 PROTHROMBIN TIME TESTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 17 FIBRINOGEN TESTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 18 ACT TESTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 19 APTT TESTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 20 D-DIMER TESTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 21 PLATELET FUNCTION TESTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 22 ANTI-FACTOR XA TESTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 23 HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 24 OTHER COAGULATION TESTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 25 COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 26 OPTICAL TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 27 MECHANICAL TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 28 ELECTROCHEMICAL TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 29 OTHER TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 30 COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 31 CLINICAL LABORATORIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 32 POINT-OF-CARE TESTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 33 OTHER END USERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 34 COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 35 LIST OF RELATED CONFERENCES HELD IN NORTH AMERICA
Table 36 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 37 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 38 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 39 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 40 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 41 U.S.: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 42 U.S.: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 43 U.S.: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 44 CANADA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 45 CANADA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 46 CANADA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 47 EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 48 EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 49 EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 50 EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 51 EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 52 GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 53 GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 54 GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 55 U.K.: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 56 U.K.: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 57 U.K.: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 58 FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 59 FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 60 FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 61 ITALY: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 62 ITALY: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 63 ITALY: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 64 SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 65 SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 66 SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 67 ROE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 68 ROE: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 69 ROE: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 70 ASIA: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 71 ASIA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 72 ASIA: COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 73 ASIA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 74 ASIA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 75 CHINA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 76 CHINA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 77 CHINA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 78 JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 79 JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 80 JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 81 INDIA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 82 INDIA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 83 INDIA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 84 ROA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 85 ROA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 86 ROA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 87 ROW: COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 88 ROW: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 89 ROW: COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 90 ROW: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014–2021 (USD MILLION)
Table 91 ROW: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 92 GROWTH STRATEGY MATRIX, 2014–2016
Table 93 PRODUCT LAUNCHES, 2014–2016
Table 94 EXPANSIONS, 2014–2016
Table 95 AGREEMENTS, 2014–2016
Table 96 OTHER DEVELOPMENTS, 2014–2016
LIST OF FIGURES
Figure 1 GLOBAL COAGULATION ANALYZERS MARKET
Figure 2 RESEARCH DESIGN
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION
Figure 4 COAGULATION ANALYZERS MARKET: BOTTOM-UP APPROACH
Figure 5 COAGULATION ANALYZERS MARKET: TOP-DOWN APPROACH
Figure 6 DATA TRIANGULATION METHODOLOGY
Figure 7 GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD BILLION)
Figure 8 GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2016 VS. 2021 (USD BILLION)
Figure 9 GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021 (USD BILLION)
Figure 10 GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2016 VS. 2021 (USD BILLION)
Figure 11 GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY REGION
Figure 12 GLOBAL COAGULATION ANALYZERS MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD
Figure 13 OPTICAL TECHNOLOGY SEGMENT TO DOMINATE THE GLOBAL COAGULATION ANALYZERS MARKET IN 2016
Figure 14 ASIAN MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 15 COAGULATION ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES & CHALLENGES
Figure 16 COAGULATION ANALYZERS MARKET SEGMENTATION, BY PRODUCT
Figure 17 CLINICAL LABORATORY ANALYZERS WILL CONTINUE TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
Figure 18 CONSUMABLES WILL CONTINUE TO DOMINATE THE CLINICAL LABORATORY ANALYZERS MARKET DURING THE FORECAST PERIOD
Figure 19 REAGENTS WILL CONTINUE TO DOMINATE THE CONSUMABLES MARKET DURING THE FORECAST PERIOD
Figure 20 AUTOMATED SYSTEMS WILL CONTINUE TO DOMINATE THE COAGULATION SYSTEMS MARKET DURING THE FORECAST PERIOD
Figure 21 PROTHROMBIN TIME TESTING SEGMENT WILL CONTINUE TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
Figure 22 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE PROTHROMBIN TIME TESTING MARKET IN 2016
Figure 23 OPTICAL TECHNOLOGY TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
Figure 24 CLINICAL LABORATORIES SEGMENT WILL CONTINUE TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
Figure 25 NORTH AMERICA TO DOMINATE THE GLOBAL COAGULATION ANALYZER MARKET IN 2016
Figure 26 THE COAGULATION ANALYZERS MARKET IN ASIA IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
Figure 27 NORTH AMERICA: COAGULATION ANALYZERS MARKET SNAPSHOT
Figure 28 THE U.S. IS ESTIMATED TO DOMINATE THE NORTH AMERICAN COAGULATION ANALYZERS MARKET IN 2016
Figure 29 CLINICAL LABORATORY ANALYZERS ARE ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE NORTH AMERICAN COAGULATION ANALYZERS MARKET IN 2016
Figure 30 CLINICAL LABORATORY ANALYZERS ARE ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE U.S. COAGULATION ANALYZERS MARKET IN 2016
Figure 31 CLINICAL LABORATORY ANALYZERS ARE EXPECTED TO DOMINATE THE COAGULATION ANALYZERS MARKET IN CANADA DURING THE FORECAST PERIOD
Figure 32 GERMANY IS ESTIMATED TO DOMINATE THE EUROPEAN COAGULATION ANALYZERS MARKET IN 2016
Figure 33 POC TESTING ANALYZERS TO REGISTER HIGHEST GROWTH IN THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
Figure 34 CLINICAL LABORATORY ANALYZERS ARE ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE COAGULATION ANALYZERS MARKET IN GERMANY IN 2016
Figure 35 CLINICAL LABORATORY ANALYZERS TO COMMAND THE COAGULATION ANALYZERS PRODUCTS MARKET IN THE U.K. IN 2016
Figure 36 CLINICAL LABORATORY ANALYZERS ESTIMATED TO DOMINATE THE FRENCH MARKET IN 2016
Figure 37 CLINICAL LABORATORY ANALYZERS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE ITALIAN COAGULATION ANALYZERS MARKET IN 2016
Figure 38 COAGULATION ANALYZERS FOR POC TESTING SEGMENT TO GROW AT THE HIGHEST RATE IN THE SPANISH MARKET
Figure 39 CLINICAL LABORATORY ANALYZERS TO HOLD LARGEST SHARE IN ROE IN 2016
Figure 40 ASIA: COAGULATION ANALYZERS MARKET SNAPSHOT
Figure 41 CHINA IS ESTIMATED TO DOMINATE THE ASIAN COAGULATION ANALYZERS MARKET IN 2016
Figure 42 CLINICAL LABORATORY ANALYZERS TO BE THE LARGEST PRODUCT SEGMENT IN ASIAN MARKET IN 2016
Figure 43 CLINICAL LABORATORY ANALYZERS TO BE THE LARGEST PRODUCT SEGMENT IN THE CHINESE COAGULATION ANALYZERS MARKET IN 2016
Figure 44 CLINICAL LABORATORY ANALYZERS TO HOLD LARGEST SHARE IN JAPANESE MARKET IN 2016
Figure 45 POC TESTING ANALYZERS TO WITNESS HIGHEST GROWTH IN THE INDIAN MARKET DURING THE FORECAST PERIOD
Figure 46 CLINICAL LABORATORY ANALYZERS, THE MAJOR PRODUCT SEGMENT IN ROA IN 2016
Figure 47 SOUTH AMERICA, CENTRAL AMERICA, AND THE CARIBBEAN TO DOMINATE THE ROW COAGULATION ANALYZERS MARKET IN 2016
Figure 48 CLINICAL LABORATORY ANALYZERS EXPECTED TO DOMINATE THE ROW MARKET, BY PRODUCT, IN 2016
Figure 49 PRODUCT LAUNCH WAS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE COAGULATION ANALYZERS MARKET
Figure 50 COAGULATION ANALYZERS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
Figure 51 GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS
Figure 52 COMPANY SNAPSHOT: ALERE INC.
Figure 53 COMPANY SNAPSHOT: NIHON KOHDEN CORPORATION
Figure 54 COMPANY SNAPSHOT: ROCHE DIAGNOSTICS
Figure 55 COMPANY SNAPSHOT: SIEMENS AG
Figure 56 COMPANY SNAPSHOT: SYSMEX CORPORATION
Figure 57 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC.
Figure 1 GLOBAL COAGULATION ANALYZERS MARKET
Figure 2 RESEARCH DESIGN
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION
Figure 4 COAGULATION ANALYZERS MARKET: BOTTOM-UP APPROACH
Figure 5 COAGULATION ANALYZERS MARKET: TOP-DOWN APPROACH
Figure 6 DATA TRIANGULATION METHODOLOGY
Figure 7 GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD BILLION)
Figure 8 GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2016 VS. 2021 (USD BILLION)
Figure 9 GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021 (USD BILLION)
Figure 10 GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2016 VS. 2021 (USD BILLION)
Figure 11 GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY REGION
Figure 12 GLOBAL COAGULATION ANALYZERS MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD
Figure 13 OPTICAL TECHNOLOGY SEGMENT TO DOMINATE THE GLOBAL COAGULATION ANALYZERS MARKET IN 2016
Figure 14 ASIAN MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 15 COAGULATION ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES & CHALLENGES
Figure 16 COAGULATION ANALYZERS MARKET SEGMENTATION, BY PRODUCT
Figure 17 CLINICAL LABORATORY ANALYZERS WILL CONTINUE TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
Figure 18 CONSUMABLES WILL CONTINUE TO DOMINATE THE CLINICAL LABORATORY ANALYZERS MARKET DURING THE FORECAST PERIOD
Figure 19 REAGENTS WILL CONTINUE TO DOMINATE THE CONSUMABLES MARKET DURING THE FORECAST PERIOD
Figure 20 AUTOMATED SYSTEMS WILL CONTINUE TO DOMINATE THE COAGULATION SYSTEMS MARKET DURING THE FORECAST PERIOD
Figure 21 PROTHROMBIN TIME TESTING SEGMENT WILL CONTINUE TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
Figure 22 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE PROTHROMBIN TIME TESTING MARKET IN 2016
Figure 23 OPTICAL TECHNOLOGY TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
Figure 24 CLINICAL LABORATORIES SEGMENT WILL CONTINUE TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
Figure 25 NORTH AMERICA TO DOMINATE THE GLOBAL COAGULATION ANALYZER MARKET IN 2016
Figure 26 THE COAGULATION ANALYZERS MARKET IN ASIA IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
Figure 27 NORTH AMERICA: COAGULATION ANALYZERS MARKET SNAPSHOT
Figure 28 THE U.S. IS ESTIMATED TO DOMINATE THE NORTH AMERICAN COAGULATION ANALYZERS MARKET IN 2016
Figure 29 CLINICAL LABORATORY ANALYZERS ARE ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE NORTH AMERICAN COAGULATION ANALYZERS MARKET IN 2016
Figure 30 CLINICAL LABORATORY ANALYZERS ARE ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE U.S. COAGULATION ANALYZERS MARKET IN 2016
Figure 31 CLINICAL LABORATORY ANALYZERS ARE EXPECTED TO DOMINATE THE COAGULATION ANALYZERS MARKET IN CANADA DURING THE FORECAST PERIOD
Figure 32 GERMANY IS ESTIMATED TO DOMINATE THE EUROPEAN COAGULATION ANALYZERS MARKET IN 2016
Figure 33 POC TESTING ANALYZERS TO REGISTER HIGHEST GROWTH IN THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
Figure 34 CLINICAL LABORATORY ANALYZERS ARE ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE COAGULATION ANALYZERS MARKET IN GERMANY IN 2016
Figure 35 CLINICAL LABORATORY ANALYZERS TO COMMAND THE COAGULATION ANALYZERS PRODUCTS MARKET IN THE U.K. IN 2016
Figure 36 CLINICAL LABORATORY ANALYZERS ESTIMATED TO DOMINATE THE FRENCH MARKET IN 2016
Figure 37 CLINICAL LABORATORY ANALYZERS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE ITALIAN COAGULATION ANALYZERS MARKET IN 2016
Figure 38 COAGULATION ANALYZERS FOR POC TESTING SEGMENT TO GROW AT THE HIGHEST RATE IN THE SPANISH MARKET
Figure 39 CLINICAL LABORATORY ANALYZERS TO HOLD LARGEST SHARE IN ROE IN 2016
Figure 40 ASIA: COAGULATION ANALYZERS MARKET SNAPSHOT
Figure 41 CHINA IS ESTIMATED TO DOMINATE THE ASIAN COAGULATION ANALYZERS MARKET IN 2016
Figure 42 CLINICAL LABORATORY ANALYZERS TO BE THE LARGEST PRODUCT SEGMENT IN ASIAN MARKET IN 2016
Figure 43 CLINICAL LABORATORY ANALYZERS TO BE THE LARGEST PRODUCT SEGMENT IN THE CHINESE COAGULATION ANALYZERS MARKET IN 2016
Figure 44 CLINICAL LABORATORY ANALYZERS TO HOLD LARGEST SHARE IN JAPANESE MARKET IN 2016
Figure 45 POC TESTING ANALYZERS TO WITNESS HIGHEST GROWTH IN THE INDIAN MARKET DURING THE FORECAST PERIOD
Figure 46 CLINICAL LABORATORY ANALYZERS, THE MAJOR PRODUCT SEGMENT IN ROA IN 2016
Figure 47 SOUTH AMERICA, CENTRAL AMERICA, AND THE CARIBBEAN TO DOMINATE THE ROW COAGULATION ANALYZERS MARKET IN 2016
Figure 48 CLINICAL LABORATORY ANALYZERS EXPECTED TO DOMINATE THE ROW MARKET, BY PRODUCT, IN 2016
Figure 49 PRODUCT LAUNCH WAS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE COAGULATION ANALYZERS MARKET
Figure 50 COAGULATION ANALYZERS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
Figure 51 GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS
Figure 52 COMPANY SNAPSHOT: ALERE INC.
Figure 53 COMPANY SNAPSHOT: NIHON KOHDEN CORPORATION
Figure 54 COMPANY SNAPSHOT: ROCHE DIAGNOSTICS
Figure 55 COMPANY SNAPSHOT: SIEMENS AG
Figure 56 COMPANY SNAPSHOT: SYSMEX CORPORATION
Figure 57 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC.
